Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells

Hyang Min Byun, Dongchul Suh, Youngsin Jeong, Seok Wee Hyung, Mogg Kim Jung, Won-Ki Kim, Jae Ko Jung, Jin Seok Kim, Bok Lee Yong, Yu Kyoung Oh

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Although prolonged transgene expression in progenitor cells might be desirable for modified cell therapy, the viral promoter-based expression vector tends to promote transgene expression only for a limited period. Here, we examined the ability of cellular promoters from elongation factor-1α (EF-1α) and ubiquitin C to drive gene expression in hematopoietic TF-1 and mesenchymal progenitor cells. We compared the expression levels and duration of a model gene, interleukin-2, generated by the cellular promoters to those by the cytomegalovirus (CMV) promoter. The EF-1α and ubiquitin C promoters drove prolonged gene expression in hematopoietic TF-1 and mesenchymal progenitor cells, whereas the CMV promoter did not. At day 7 after transfection in TF-1 cells, the mRNA expression levels of interleukin-2 driven by the EF-1α and ubiquitin C promoters were 118- and 56-fold higher, respectively, than those driven by the CMV promoter. Similarly, in mesenchymal progenitor cells, the expression levels of interleukin-2 driven by the EF-1α and ubiquitin C promoters were 98- and 20-fold higher, respectively, than that driven by the CMV promoter-encoding plasmid. Moreover, the ubiquitin C promoter directed higher levels of green fluorescence protein expression in mesenchymal progenitor cells than did the CMV promoter. These results indicate that the use of cellular promoters such as those for EF-1α and ubiquitin C might direct prolonged gene expression in hematopoietic and mesenchymal progenitor cells.

Original languageEnglish
Pages (from-to)518-523
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume332
Issue number2
DOIs
Publication statusPublished - 2005 Jul 1
Externally publishedYes

Fingerprint

Ubiquitin C
Peptide Elongation Factor 1
Hematopoietic Stem Cells
Mesenchymal Stromal Cells
Gene expression
Cytomegalovirus
Plasmids
Gene Expression
Interleukin-2
Transgenes
Cell- and Tissue-Based Therapy
Transfection
Stem Cells
Genes
Fluorescence
Messenger RNA

Keywords

  • Elongation factor-1α
  • Hematopoietic cells
  • Mesenchymal progenitor cells
  • Promoters
  • Ubiquitin C

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells. / Byun, Hyang Min; Suh, Dongchul; Jeong, Youngsin; Hyung, Seok Wee; Jung, Mogg Kim; Kim, Won-Ki; Jung, Jae Ko; Kim, Jin Seok; Yong, Bok Lee; Oh, Yu Kyoung.

In: Biochemical and Biophysical Research Communications, Vol. 332, No. 2, 01.07.2005, p. 518-523.

Research output: Contribution to journalArticle

Byun, Hyang Min ; Suh, Dongchul ; Jeong, Youngsin ; Hyung, Seok Wee ; Jung, Mogg Kim ; Kim, Won-Ki ; Jung, Jae Ko ; Kim, Jin Seok ; Yong, Bok Lee ; Oh, Yu Kyoung. / Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells. In: Biochemical and Biophysical Research Communications. 2005 ; Vol. 332, No. 2. pp. 518-523.
@article{bc0d9f3ad03d4615aa92542c0c830364,
title = "Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells",
abstract = "Although prolonged transgene expression in progenitor cells might be desirable for modified cell therapy, the viral promoter-based expression vector tends to promote transgene expression only for a limited period. Here, we examined the ability of cellular promoters from elongation factor-1α (EF-1α) and ubiquitin C to drive gene expression in hematopoietic TF-1 and mesenchymal progenitor cells. We compared the expression levels and duration of a model gene, interleukin-2, generated by the cellular promoters to those by the cytomegalovirus (CMV) promoter. The EF-1α and ubiquitin C promoters drove prolonged gene expression in hematopoietic TF-1 and mesenchymal progenitor cells, whereas the CMV promoter did not. At day 7 after transfection in TF-1 cells, the mRNA expression levels of interleukin-2 driven by the EF-1α and ubiquitin C promoters were 118- and 56-fold higher, respectively, than those driven by the CMV promoter. Similarly, in mesenchymal progenitor cells, the expression levels of interleukin-2 driven by the EF-1α and ubiquitin C promoters were 98- and 20-fold higher, respectively, than that driven by the CMV promoter-encoding plasmid. Moreover, the ubiquitin C promoter directed higher levels of green fluorescence protein expression in mesenchymal progenitor cells than did the CMV promoter. These results indicate that the use of cellular promoters such as those for EF-1α and ubiquitin C might direct prolonged gene expression in hematopoietic and mesenchymal progenitor cells.",
keywords = "Elongation factor-1α, Hematopoietic cells, Mesenchymal progenitor cells, Promoters, Ubiquitin C",
author = "Byun, {Hyang Min} and Dongchul Suh and Youngsin Jeong and Hyung, {Seok Wee} and Jung, {Mogg Kim} and Won-Ki Kim and Jung, {Jae Ko} and Kim, {Jin Seok} and Yong, {Bok Lee} and Oh, {Yu Kyoung}",
year = "2005",
month = "7",
day = "1",
doi = "10.1016/j.bbrc.2005.04.155",
language = "English",
volume = "332",
pages = "518--523",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells

AU - Byun, Hyang Min

AU - Suh, Dongchul

AU - Jeong, Youngsin

AU - Hyung, Seok Wee

AU - Jung, Mogg Kim

AU - Kim, Won-Ki

AU - Jung, Jae Ko

AU - Kim, Jin Seok

AU - Yong, Bok Lee

AU - Oh, Yu Kyoung

PY - 2005/7/1

Y1 - 2005/7/1

N2 - Although prolonged transgene expression in progenitor cells might be desirable for modified cell therapy, the viral promoter-based expression vector tends to promote transgene expression only for a limited period. Here, we examined the ability of cellular promoters from elongation factor-1α (EF-1α) and ubiquitin C to drive gene expression in hematopoietic TF-1 and mesenchymal progenitor cells. We compared the expression levels and duration of a model gene, interleukin-2, generated by the cellular promoters to those by the cytomegalovirus (CMV) promoter. The EF-1α and ubiquitin C promoters drove prolonged gene expression in hematopoietic TF-1 and mesenchymal progenitor cells, whereas the CMV promoter did not. At day 7 after transfection in TF-1 cells, the mRNA expression levels of interleukin-2 driven by the EF-1α and ubiquitin C promoters were 118- and 56-fold higher, respectively, than those driven by the CMV promoter. Similarly, in mesenchymal progenitor cells, the expression levels of interleukin-2 driven by the EF-1α and ubiquitin C promoters were 98- and 20-fold higher, respectively, than that driven by the CMV promoter-encoding plasmid. Moreover, the ubiquitin C promoter directed higher levels of green fluorescence protein expression in mesenchymal progenitor cells than did the CMV promoter. These results indicate that the use of cellular promoters such as those for EF-1α and ubiquitin C might direct prolonged gene expression in hematopoietic and mesenchymal progenitor cells.

AB - Although prolonged transgene expression in progenitor cells might be desirable for modified cell therapy, the viral promoter-based expression vector tends to promote transgene expression only for a limited period. Here, we examined the ability of cellular promoters from elongation factor-1α (EF-1α) and ubiquitin C to drive gene expression in hematopoietic TF-1 and mesenchymal progenitor cells. We compared the expression levels and duration of a model gene, interleukin-2, generated by the cellular promoters to those by the cytomegalovirus (CMV) promoter. The EF-1α and ubiquitin C promoters drove prolonged gene expression in hematopoietic TF-1 and mesenchymal progenitor cells, whereas the CMV promoter did not. At day 7 after transfection in TF-1 cells, the mRNA expression levels of interleukin-2 driven by the EF-1α and ubiquitin C promoters were 118- and 56-fold higher, respectively, than those driven by the CMV promoter. Similarly, in mesenchymal progenitor cells, the expression levels of interleukin-2 driven by the EF-1α and ubiquitin C promoters were 98- and 20-fold higher, respectively, than that driven by the CMV promoter-encoding plasmid. Moreover, the ubiquitin C promoter directed higher levels of green fluorescence protein expression in mesenchymal progenitor cells than did the CMV promoter. These results indicate that the use of cellular promoters such as those for EF-1α and ubiquitin C might direct prolonged gene expression in hematopoietic and mesenchymal progenitor cells.

KW - Elongation factor-1α

KW - Hematopoietic cells

KW - Mesenchymal progenitor cells

KW - Promoters

KW - Ubiquitin C

UR - http://www.scopus.com/inward/record.url?scp=21144457927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21144457927&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.04.155

DO - 10.1016/j.bbrc.2005.04.155

M3 - Article

VL - 332

SP - 518

EP - 523

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 2

ER -